Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: Medochemie Ltd, 1–10 Constantinoupoleus Street 3011 Limassol, Cyprus
Zepilen 500 mg powder for solution for injection/infusion.
Zepilen 1g powder for solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion. White or almost white, very hygroscopic powder for solution for injection/infusion. |
Each vial of Zepilen 500 mg contains 500 mg of cefazolin as cefazolin sodium.
Each vial of Zepilen 1 g contains 1 g of cefazolin as cefazolin sodium.
Excipient with known effect: sodium.
Zepilen 1g contains 2.2 mmol (50.72 mg) sodium per vial.
Zepilen 500 mg contains 1.1 mmol (25.36 mg) sodium per vial.
| Active Ingredient | Description | |
|---|---|---|
| Cefazolin |
Cefazolin is a bactericidal cephalosporin antibiotic of the first generation for parenteral administration. Cephalosporins inhibit cell wall synthesis (in the growth stage) through blocking the penicillin-binding proteins (PBPs) like transpeptidases. The outcome is a bactericidal action. |
| List of Excipients |
|---|
|
Zepilen contains no excipients. |
Clear, colourless type I glass vials, sealed with a grey bromobutyl stopper and an aluminium overcap.
Each vial contains either 500 mg, or 1 g of cefazolin as cefazolin sodium. Cartons containing 1, 10, 50 or 100 vials are available.
Not all pack sizes may be marketed.
Medochemie Ltd, 1–10 Constantinoupoleus Street 3011 Limassol, Cyprus
Zepilen 500mg: 12523
Zepilen 1g: 12771
Zepilen 500mg: 14.12.1989 / 17.12.2012
Zepilen 1g: 06.07.1990 / 30.07.2013
| Drug | Countries | |
|---|---|---|
| ZEPILEN | Cyprus, Estonia, Spain, Croatia, Lithuania, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
